News
EVAX
5.46
-4.38%
-0.25
Evaxion A/S Announces 2026 Financial Calendar
TipRanks · 2d ago
Evaxion A/S to Report Full Year 2025 Financial Results
Reuters · 2d ago
Evaxion Biotech’s Promising Future: Strategic Partnerships and Key Catalysts Drive Growth Potential
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX), 4D Molecular Therapeutics (FDMT) and Arcturus Therapeutics (ARCT)
TipRanks · 3d ago
Weekly Report: what happened at EVAX last week (1103-1107)?
Weekly Report · 4d ago
Evaxion Biotech’s Earnings Call Highlights Strategic Growth
TipRanks · 6d ago
Evaxion Unveils New Immune Data for AI-Designed Cancer Vaccine
TipRanks · 11/07 22:52
Evaxion Announces New Data Exploring Immune Responses Following Treatment With AI-designed Personalized Cancer Vaccine EVX-01
Benzinga · 11/07 22:16
Evaxion Unveils New Immune Data From Phase 2 Trial of AI-Designed Cancer Vaccine EVX-01
Reuters · 11/07 22:10
Lake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX)
TipRanks · 11/07 16:16
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Barchart · 11/07 16:10
Evaxion Biotech Announces New CEO and Promising Vaccine Developments
TipRanks · 11/06 13:14
Techbio firm Evaxion posts Q3 net income of $4.6 mln
Reuters · 11/06 12:44
Evaxion Biotech ADS GAAP EPS of $0.01 beats by $0.02, revenue of $7.49M beats by $4.99M
Seeking Alpha · 11/06 12:37
Evaxion A/S posts Q3 net profit of $4.6 million on revenue of $7.5 million
Reuters · 11/06 12:31
Earnings Scheduled For November 6, 2025
Benzinga · 11/06 11:12
Evaxion announces business update and third quarter 2025 financial results
Barchart · 11/06 06:30
What's Next: Evaxion Biotech's Earnings Preview
Benzinga · 11/05 20:02
Evaxion Unveils AI-Designed Cancer Vaccine Candidate EVX-04
TipRanks · 11/03 14:48
Evaxion Biotech expands R&D pipeline with EVX-04
TipRanks · 11/03 14:11
More
Webull provides a variety of real-time EVAX stock news. You can receive the latest news about Evaxion AS through multiple platforms. This information may help you make smarter investment decisions.
About EVAX
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.